recombinant human neuregulin-1β

neuregulin-1β · Zensun Science & Technology Co., Ltd.

Drug timelines are a Plus or Pro feature.

6 regulatory and trial events tracked for recombinant human neuregulin-1β, covering 2017-12-21 to 2024-02-01. Get the full timeline:

Most recent: Clinical Trial Update: Survival Study of the Recombinant Human Neuregulin-1β in Subjects With Chronic Heart Failure. [Phase 3]